Upload
vuongquynh
View
217
Download
4
Embed Size (px)
Citation preview
Hye Kyung Chang, JungHye Kyung Chang, JungHye Kyung Chang, JungHye Kyung Chang, Jung----Tak Oh, Seung Hoon Choi, Seok Joo HanTak Oh, Seung Hoon Choi, Seok Joo HanTak Oh, Seung Hoon Choi, Seok Joo HanTak Oh, Seung Hoon Choi, Seok Joo Han
Division of Pediatric Surgery, Department of Surgery,Division of Pediatric Surgery, Department of Surgery,Division of Pediatric Surgery, Department of Surgery,Division of Pediatric Surgery, Department of Surgery,Yonsei University College of MedicineYonsei University College of MedicineYonsei University College of MedicineYonsei University College of Medicine
Home Intravenous Antibiotic Treatment for Home Intravenous Antibiotic Treatment for Home Intravenous Antibiotic Treatment for Home Intravenous Antibiotic Treatment for Intractable Cholangitis in Biliary AtresiaIntractable Cholangitis in Biliary AtresiaIntractable Cholangitis in Biliary AtresiaIntractable Cholangitis in Biliary Atresia
BackgroundBackgroundBackgroundBackgroundCholangitisCholangitisCholangitisCholangitis
common complication during follow up of biliary atresia after Kasai operation
Intractable Cholangitis (IC)Intractable Cholangitis (IC)Intractable Cholangitis (IC)Intractable Cholangitis (IC)
- uncontrolled cholangitis by routine conservative treatment
-may cause biliary cirrhosis, hepatic failure, portal hypertension
- most important and difficult complicationin management after Kasai portoenterostomy
: poor prognosis and the occasional requirement of liver transplantation
Intrahepatic Biliary CystIntrahepatic Biliary CystIntrahepatic Biliary CystIntrahepatic Biliary Cyst
may be the source of biliary infection
BackgroundBackgroundBackgroundBackground
- review of the effects and the role of home intravenous antibiotic treatment (HIVA) in 8 patients of post-Kasai intractable cholangitis with
biliary atresia
- suggestion of HIVA as an effective method for management of intractable cholangitis and intrahepatic biliary cysts in post-Kasai patients
Management of intractable cholangitis and intrahepatic biliary cManagement of intractable cholangitis and intrahepatic biliary cManagement of intractable cholangitis and intrahepatic biliary cManagement of intractable cholangitis and intrahepatic biliary cystsystsystsysts
- many surgical or medical trialsto control cholangitis and intrahepatic biliary cysts
- no treatment of choice of intractable cholangitis or intrahepatic biliary cysts
PurposePurposePurposePurpose
retrospective review of medical recordsretrospective review of medical recordsretrospective review of medical recordsretrospective review of medical recordsfor whom
- treated by HIVA for IC after successful Kasai portoenterostomy with BA - from 1998 to 2008- at Severance Hospital and Yongdong Severance Hospital
diagnostic criteria of cholangitisdiagnostic criteria of cholangitisdiagnostic criteria of cholangitisdiagnostic criteria of cholangitis
1)clinical symptoms such as fever, abdominal pain, jaundice or acholic stool2)laboratory data such as hyperbilirubinemia, elevated liver enzyme
or isolation of bacteria on blood culture3)without other fever focus such as upper respiratory tract infection or
urinary tract infection
MethodsMethodsMethodsMethods
diagnostic criteria of intractable cholangitisdiagnostic criteria of intractable cholangitisdiagnostic criteria of intractable cholangitisdiagnostic criteria of intractable cholangitis
recurrent cholangitis unresponsive to conservative managementwith intravenous antibiotics treatment
1)duration of admission for treatment longer than 1 month
2)three times of admission due to cholangitiswith duration between previous discharge and readmission
less than 1 month
detection of intrahepatic biliary cystdetection of intrahepatic biliary cystdetection of intrahepatic biliary cystdetection of intrahepatic biliary cyst
Abdominal ultrasonographyAbdominal CT
central venous catheter indwellingcentral venous catheter indwellingcentral venous catheter indwellingcentral venous catheter indwelling
during the HIVA treatment
MethodsMethodsMethodsMethods
ResultsResultsResultsResultsIntractable cholangitis (IC) after successful Kasai operation
in 10 cases during last decade
to settle IC, intrahepatic cysts were drained in the first two patientsbut IC was not controlled
Intrahepatic cysts in case IIntrahepatic cysts in case IIntrahepatic cysts in case IIntrahepatic cysts in case I Remained intrahepatic cysts after Remained intrahepatic cysts after Remained intrahepatic cysts after Remained intrahepatic cysts after hepatic cystojejunostomy in case Ihepatic cystojejunostomy in case Ihepatic cystojejunostomy in case Ihepatic cystojejunostomy in case I
ResultsResultsResultsResultsHIVA program in the patients diagnosed as ICHIVA program in the patients diagnosed as ICHIVA program in the patients diagnosed as ICHIVA program in the patients diagnosed as IC
after insertion of central venous catheterwith help of home care nursing in 10 cases
two patients of initial period of HIVA were not followed upbecause of transfer to other hospital
Duration of HIVADuration of HIVADuration of HIVADuration of HIVA
from 8 to 39 months with median value of 13.5 months
two patients on HIVAduration of 8 months for one patient and 15 months for the other
six patients off HIVAfrom 8 to 39 months of duration with median value of 14 months
Patient Patient Patient Patient NumberNumberNumberNumber
SexSexSexSexAge of Kasai Age of Kasai Age of Kasai Age of Kasai op. (months)op. (months)op. (months)op. (months)
Age of ICAge of ICAge of ICAge of IC(months)(months)(months)(months)
IHCIHCIHCIHCAge of HIVA Age of HIVA Age of HIVA Age of HIVA
(months)(months)(months)(months)Duration b/w IC Duration b/w IC Duration b/w IC Duration b/w IC ––––
HIVA (months)HIVA (months)HIVA (months)HIVA (months)
1111 FFFF 2222⅓⅓⅓⅓ 6666 YYYY 60606060 44444444
2222 MMMM 2222⅔⅔⅔⅔ 5555 YYYY 33333333 28282828
3333 FFFF 2222 8888 YYYY 10101010 2222
44441)1)1)1) FFFF 11111111////2222 5555 YYYY 9999 4444
5555 FFFF 1111⅓⅓⅓⅓ 12121212 YYYY 12121212 0000
6666 FFFF 11111111////2222 4444 YYYY 5555 1111
7777 FFFF 11112222////3333 12121212 NNNN 13131313 1111
8888 FFFF 22221111////2222 35353535 YYYY 36363636 1111
Clinical Characteristics of Patients on HIVAClinical Characteristics of Patients on HIVAClinical Characteristics of Patients on HIVAClinical Characteristics of Patients on HIVA
IC : intractable cholangitisIC : intractable cholangitisIC : intractable cholangitisIC : intractable cholangitisIHC : intrahepatic cystIHC : intrahepatic cystIHC : intrahepatic cystIHC : intrahepatic cystHIVA : home intravenous antibiotic treatmentHIVA : home intravenous antibiotic treatmentHIVA : home intravenous antibiotic treatmentHIVA : home intravenous antibiotic treatment1) Kasai op. at other hospital1) Kasai op. at other hospital1) Kasai op. at other hospital1) Kasai op. at other hospital
PTBDPTBDPTBDPTBDAlcohol sclerosing Tx.Alcohol sclerosing Tx.Alcohol sclerosing Tx.Alcohol sclerosing Tx.
Alcohol Alcohol Alcohol Alcohol sclerosing Tx.sclerosing Tx.sclerosing Tx.sclerosing Tx.
PTBDPTBDPTBDPTBD
Hepatic cystojejunostomyHepatic cystojejunostomyHepatic cystojejunostomyHepatic cystojejunostomy
Revision of Revision of Revision of Revision of portoenterostomyportoenterostomyportoenterostomyportoenterostomy
PTBDPTBDPTBDPTBDMetal stent insertionMetal stent insertionMetal stent insertionMetal stent insertion
Clinical CoursesClinical CoursesClinical CoursesClinical Courses
Clinical CoursesClinical CoursesClinical CoursesClinical Courses
ShortShortShortShort----term Results of HIVAterm Results of HIVAterm Results of HIVAterm Results of HIVA
Patient Patient Patient Patient NumberNumberNumberNumber
Duration of HIVADuration of HIVADuration of HIVADuration of HIVA(months)(months)(months)(months)
Disappearance of IHCDisappearance of IHCDisappearance of IHCDisappearance of IHC1)1)1)1) Duration of Initial Ch.Duration of Initial Ch.Duration of Initial Ch.Duration of Initial Ch.----free Status free Status free Status free Status after HIVA (months)after HIVA (months)after HIVA (months)after HIVA (months)
1111 18181818 YYYY 42424242
2222 16161616 YYYY 13131313
3333 8888 YYYY 13131313
4444 39393939 YYYY 13131313
5555 9999 YYYY 52525252
6666 12121212 YYYY 31313131
7777 15 (on Tx.)15 (on Tx.)15 (on Tx.)15 (on Tx.) ----2)2)2)2) 3333
8888 8 (on Tx.)8 (on Tx.)8 (on Tx.)8 (on Tx.) NNNN 3333
IHC : intrahepatic cystIHC : intrahepatic cystIHC : intrahepatic cystIHC : intrahepatic cystCh. : cholangitisCh. : cholangitisCh. : cholangitisCh. : cholangitis1)1)1)1) detected by imaging studies (abd. U/S or CT)detected by imaging studies (abd. U/S or CT)detected by imaging studies (abd. U/S or CT)detected by imaging studies (abd. U/S or CT)2)2)2)2) no previously detected intrahepatic cystno previously detected intrahepatic cystno previously detected intrahepatic cystno previously detected intrahepatic cyst
PatientPatientPatientPatientNumberNumberNumberNumber
Duration of Duration of Duration of Duration of AdmissionAdmissionAdmissionAdmission1)1)1)1)
before HIVAbefore HIVAbefore HIVAbefore HIVA(days)(days)(days)(days)
DurationDurationDurationDurationbefore HIVAbefore HIVAbefore HIVAbefore HIVA(months)(months)(months)(months)2)2)2)2)
AdmissionAdmissionAdmissionAdmissionRatioRatioRatioRatio3)3)3)3) beforebeforebeforebefore
HIVAHIVAHIVAHIVA
Duration ofDuration ofDuration ofDuration ofAdmissionAdmissionAdmissionAdmission1)1)1)1)
after HIVAafter HIVAafter HIVAafter HIVA(days)(days)(days)(days)
DurationDurationDurationDurationafter HIVAafter HIVAafter HIVAafter HIVA(months)(months)(months)(months)4)4)4)4)
AdmissionAdmissionAdmissionAdmissionRatioRatioRatioRatio3)3)3)3) afterafterafterafter
HIVAHIVAHIVAHIVA
1111 318318318318 73737373 4.44.44.44.4 7777 36363636 0.20.20.20.2
2222 287287287287 29292929 9.99.99.99.9 58585858 55555555 1.11.11.11.1
3333 109109109109 12121212 9.19.19.19.1 102102102102 51515151 2.02.02.02.0
4444 232232232232 45454545 5.25.25.25.2 0000 9999 0.00.00.00.0
5555 93939393 15151515 6.26.26.26.2 0000 43434343 0.00.00.00.0
6666 67676767 13131313 5.25.25.25.2 0000 26262626 0.00.00.00.0
7777 70707070 10101010 7.07.07.07.0 616161615)5)5)5) 13131313 4.74.74.74.7
8888 141141141141 30303030 4.74.74.74.7 262626265)5)5)5) 8888 3.33.33.33.3
MedianMedianMedianMedian 125125125125 22222222 5.75.75.75.7 16.516.516.516.5 31313131 0.60.60.60.6
1) Admission due to cholangitis1) Admission due to cholangitis1) Admission due to cholangitis1) Admission due to cholangitis2) Duration from diagnosis of intractable cholangitis to HIVA2) Duration from diagnosis of intractable cholangitis to HIVA2) Duration from diagnosis of intractable cholangitis to HIVA2) Duration from diagnosis of intractable cholangitis to HIVA3) Admission days / duration in months3) Admission days / duration in months3) Admission days / duration in months3) Admission days / duration in months4) Duration from HIVA to last follow up4) Duration from HIVA to last follow up4) Duration from HIVA to last follow up4) Duration from HIVA to last follow up5) Admission during HIVA5) Admission during HIVA5) Admission during HIVA5) Admission during HIVA
Effect of HIVA on Admission Rate due to CholangitisEffect of HIVA on Admission Rate due to CholangitisEffect of HIVA on Admission Rate due to CholangitisEffect of HIVA on Admission Rate due to Cholangitis
1) Wilcoxon Signed Ranks Test1) Wilcoxon Signed Ranks Test1) Wilcoxon Signed Ranks Test1) Wilcoxon Signed Ranks Test
Before HIVA Before HIVA Before HIVA Before HIVA After HIVAAfter HIVAAfter HIVAAfter HIVA PPPP----ValueValueValueValue1)1)1)1)
5.7 (4.4 5.7 (4.4 5.7 (4.4 5.7 (4.4 ---- 9.9)9.9)9.9)9.9) 0.6 (0.0 0.6 (0.0 0.6 (0.0 0.6 (0.0 –––– 4.7)4.7)4.7)4.7) 0.0120.0120.0120.012
Admission RatioAdmission RatioAdmission RatioAdmission Ratio(Admission days / duration in months) (Admission days / duration in months) (Admission days / duration in months) (Admission days / duration in months)
Effect of HIVA on Admission Rate due to CholangitisEffect of HIVA on Admission Rate due to CholangitisEffect of HIVA on Admission Rate due to CholangitisEffect of HIVA on Admission Rate due to Cholangitis
Results of HIVAResults of HIVAResults of HIVAResults of HIVA
LongLongLongLong----term Results of HIVAterm Results of HIVAterm Results of HIVAterm Results of HIVA
Patient Patient Patient Patient NumberNumberNumberNumber
Duration of Duration of Duration of Duration of FollowFollowFollowFollow----up after up after up after up after HIVA (months)HIVA (months)HIVA (months)HIVA (months)
Ch. on Last Ch. on Last Ch. on Last Ch. on Last FollowFollowFollowFollow----upupupup
Duration of Last Duration of Last Duration of Last Duration of Last Ch.Ch.Ch.Ch.----free Status free Status free Status free Status
after HIVA after HIVA after HIVA after HIVA (months)(months)(months)(months)
Recurrence of Recurrence of Recurrence of Recurrence of IHCIHCIHCIHC1)1)1)1)
Duration of IHCDuration of IHCDuration of IHCDuration of IHC----free Status free Status free Status free Status (months) (months) (months) (months)
1111 37373737 YYYY 42424242 YYYY 35353535
2222 47474747 YYYY 27272727 YYYY 34343434
3333 51515151 NNNN 12121212 NNNN 33333333
4444 9999 NNNN 13131313 NNNN 50505050
5555 43434343 NNNN 52525252 NNNN 42424242
6666 24242424 NNNN 31313131 NNNN 32323232
7777 ----2)2)2)2) NNNN 3333 ----3)3)3)3) ----3)3)3)3)
8888 ----2)2)2)2) NNNN 3333 ----2)2)2)2) ----2)2)2)2)
Ch. : cholangitis, IHC : intrahepatic cystCh. : cholangitis, IHC : intrahepatic cystCh. : cholangitis, IHC : intrahepatic cystCh. : cholangitis, IHC : intrahepatic cyst1)1)1)1) detected by imaging studies (abd. U/S or CT)detected by imaging studies (abd. U/S or CT)detected by imaging studies (abd. U/S or CT)detected by imaging studies (abd. U/S or CT)2)2)2)2) on HIVA treatmenton HIVA treatmenton HIVA treatmenton HIVA treatment3)3)3)3) no previously detected intrahepatic cystno previously detected intrahepatic cystno previously detected intrahepatic cystno previously detected intrahepatic cyst
LongLongLongLong----term Results of HIVAterm Results of HIVAterm Results of HIVAterm Results of HIVA
Patient Patient Patient Patient NumberNumberNumberNumber
Age on Last Age on Last Age on Last Age on Last FollowFollowFollowFollow----up (yrs)up (yrs)up (yrs)up (yrs)
T.Bb (mg/dL)T.Bb (mg/dL)T.Bb (mg/dL)T.Bb (mg/dL) Alb (g/dL)Alb (g/dL)Alb (g/dL)Alb (g/dL) PT (INR)PT (INR)PT (INR)PT (INR) Ascites*Ascites*Ascites*Ascites*
1111 10101010 1.11.11.11.1 3.93.93.93.9 1.281.281.281.28 NNNN
2222 8888 0.70.70.70.7 3.93.93.93.9 1.551.551.551.55 NNNN
3333 5555 0.60.60.60.6 5.05.05.05.0 1.021.021.021.02 NNNN
4444 4444 0.90.90.90.9 4.94.94.94.9 0.990.990.990.99 NNNN
5555 5555 2.12.12.12.1 3.13.13.13.1 1.061.061.061.06 NNNN
6666 3333 0.70.70.70.7 5.25.25.25.2 1.151.151.151.15 NNNN
7777 2222 0.90.90.90.9 3.93.93.93.9 1.131.131.131.13 NNNN
8888 3333 1.21.21.21.2 3.53.53.53.5 1.161.161.161.16 SmSmSmSm
T.Bb : serum total bilirubin, Alb : serum albuminT.Bb : serum total bilirubin, Alb : serum albuminT.Bb : serum total bilirubin, Alb : serum albuminT.Bb : serum total bilirubin, Alb : serum albuminPT : prothrombin time, INR : international normalized ratio of PPT : prothrombin time, INR : international normalized ratio of PPT : prothrombin time, INR : international normalized ratio of PPT : prothrombin time, INR : international normalized ratio of PTTTTSm : small amount of ascites, * : detected in U/S or CTSm : small amount of ascites, * : detected in U/S or CTSm : small amount of ascites, * : detected in U/S or CTSm : small amount of ascites, * : detected in U/S or CT
-Intractable cholangitis after successful Kasai portoenterostomy can be controlled by HIVA treatment with statistically significantreduction of admission period due to cholangitis (p=0.012).
-The duration of cholangitis free in HIVA-off group ranged from 12 to 52 months (median value of 29 months).
-Intrahepatic cysts related to intractable cholangitis also can becontrolled and disappeared by HIVA treatment.
- Hepatic function is maintained good in all 8 patients of HIVA.
SummarySummarySummarySummary
ConclusionConclusionConclusionConclusion
-HIVA may be an effective primary treatment for intractablecholangitis after Kasai operation in biliary atresia.
-All of the 8 patients with HIVA for IC have tolerable hepatic function by control of cholangitis and following biliary cirrhosis. No patient required liver transplantation due to chronic liver disease or hepatic failure.
-Early application of HIVA to intractable cholangitis may help tomaintain the hepatic function without recurrence of cholangitis or intrahepatic biliary cysts.
-Early detection of intrahepatic biliary cysts or early diagnosis of intractable cholangitis are necessary for early HIVA application.